Segment Reporting - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2023 USD ($) Segment	Dec. 31, 2022 USD ($)	Dec. 31, 2020
Segment Reporting Information [Line Items]
Number of operating business segment | Segment	1
Property, plant and equipment, net | $	$ 18,856	$ 32,451
Revenue | UCB | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	40.00%	37.00%	23.00%
Revenue | Baxalta Incorporated Or Takeda P L C | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	21.00%	25.00%	16.00%
Revenue | Astra Zeneca Ab | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	11.00%	14.00%	13.00%
Revenue | Pfizer | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers	10.00%	11.00%
Revenue | BMS | Customer Concentration Risk
Segment Reporting Information [Line Items]
Percentage revenue from customers			36.00%